MedPath

First Affiliated Hospital of Wenzhou Medical University

People's Republic of China
Ownership
Private
Established
1956-01-01
Employees
-
Market Cap
-
Website
http://www.dyyy.xjtu.edu.cn/

Clinical Trials

48

Active:0
Completed:4

Trial Phases

5 Phases

Early Phase 1:4
Phase 1:1
Phase 2:9
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials

Not Applicable
12 (38.7%)
Phase 2
9 (29.0%)
Phase 4
5 (16.1%)
Early Phase 1
4 (12.9%)
Phase 1
1 (3.2%)

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

Not Applicable
Not yet recruiting
Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
Biological: Cell injection
First Posted Date
2025-03-21
Last Posted Date
2025-03-21
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
35
Registration Number
NCT06888752

Positive Psychological Intervention for Parkinson's Disease Patients

Not Applicable
Completed
Conditions
Parkinson
First Posted Date
2025-02-18
Last Posted Date
2025-02-18
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
60
Registration Number
NCT06832358
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Not Applicable
Not yet recruiting
Conditions
Myasthenia Gravis
Autoimmune Diseases
Neuromuscular Diseases
Interventions
Drug: Efgartigimod + Telitacicept (1-week interval) group
Drug: Efgartigimod + Telitacicept (2-week interval) group
Drug: Telitacicept-only group
First Posted Date
2025-02-14
Last Posted Date
2025-02-14
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
60
Registration Number
NCT06827587

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

Phase 4
Not yet recruiting
Conditions
Myasthenia Gravis
Autoimmune Diseases
Interventions
First Posted Date
2024-12-09
Last Posted Date
2024-12-09
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
30
Registration Number
NCT06723548

Study on Aging and Cognitive Impairment in China

Recruiting
Conditions
Cognitive Dysfunction
Aging
First Posted Date
2024-11-07
Last Posted Date
2024-11-07
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
20000
Registration Number
NCT06679296
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.